Download PDF
CC BY 4.0 · Surg J (N Y) 2021; 07(03): e226-e236
DOI: 10.1055/s-0041-1731447
Original Article

Prospective Comparative Observational Study of Safety and Efficacy of Topical Ozone Gas Therapy in Healing of Diabetic Foot Ulcers versus Only Conventional Wound Management

Suchin Dhamnaskar 
1   Department of Surgery, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra, India
,
Nishant Gobbur
1   Department of Surgery, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra, India
,
Mandar Koranne
1   Department of Surgery, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra, India
,
Dhaval Vasa
1   Department of Surgery, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

The prevalence of diabetic foot ulcers (DFUs) in India is 11.6%. DFU accounts for major cost expenditure, morbidity, and mortality.[1] Ozone gas has antimicrobial and antioxidant properties. We studied efficacy of topical ozone gas therapy in promoting healing of DFU. This is an observational comparative cohort study, n = 160, There were two groups of patients namely: those who received Conventional wound management alone C and those who received topical ozone therapy in addition to conventional wound management O + C therapy groups (81 each). Study group, i.e., O + C received five alternate day sessions of ozone therapy by bagging method for 30 minutes each session. Both groups were observed for 30 days for wound healing parameters like reduction of wound surface area, wound diameter, presence and character of discharge, granulation tissue, healing wound edges, microbial negativity, and requirement of revision (re-debridement and/or amputation) surgery. Mean baseline ulcer surface area is 17.43 ± 8.6 cm2 for C and 17.87 ± 9.2 cm2 (range 1–50 cm2) in O + C group. Percentage change in ulcer surface after 21 days in O + C group is 32.37% compared with 17.15% in C group, which is statistically significant (p = 0.01). Rates of microbial negativity and ulcer healing were significantly faster in ozone group. There was a statistically significant decrease in hospital stay, number of revision surgeries required, and mortality in ozone group. Topical ozone gas was well tolerated. Our study supports the efficacy of ozone therapy in DFU healing and reduction in the chances of infection and revision (re-debridement and/or amputation) surgery. More research is needed for dose, duration, and exposure time standardization.

Keywords

diabetic foot ulcers - topical ozone gas therapy - wound healing


Publication History

Received: 15 February 2021

Accepted: 17 May 2021

Article published online:
14 September 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Joshi SR. Diabetes care in India. Ann Glob Health 2015; 81 (06) 830-838
    CrossrefPubMedGoogle Scholar
  • 2 Liu J, Zhang P, Tian J. et al. Ozone therapy for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev 2015; (10) CD008474
    PubMedGoogle Scholar
  • 3 Zhang J, Guan M, Xie C, Luo X, Zhang Q, Xue Y. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxid Med Cell Longev 2014; 2014: 273475
    CrossrefPubMedGoogle Scholar
  • 4 Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006; 37 (04) 425-435
    CrossrefPubMedGoogle Scholar
  • 5 Wainstein J, Feldbrin Z, Boaz M, Harman-Boehm I. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther 2011; 13 (12) 1255-1260
    CrossrefPubMedGoogle Scholar
  • 6 Martínez-Sánchez G, Schwartz A, Di Donna V. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel) 2020; 09 (05) 389
    CrossrefPubMedGoogle Scholar
  • 7 German I, de Castro R, Andreo JC. et al. Major biological effects of ozone therapy. Accessed December 10, 2019 at: https://www.researchgate.net/figure/Major-biological-effects-of-ozone-therapy_fig1_262662651
    PubMedGoogle Scholar
  • 8 Bocci V. Ozone: A New Medical Drug. Dordrecht: Springer Netherlands; 2005: 1-295
    Google Scholar
  • 9 Seidler V, Linetskiy I, Hubálková H, Stanková H, Smucler R, Mazánek J. Ozone and its usage in general medicine and dentistry. A review article. Prague Med Rep 2008; 109 (01) 5-13
    PubMedGoogle Scholar
  • 10 Medina A, Fry M. Ozonoterapia en odontología: Tratamiento alternativo en Periodoncia. JPAPO 2019; 03 (01) 57-64
    PubMedGoogle Scholar
  • 11 Bocci V, Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes. Haematologica 1990; 75 (06) 510-515
    PubMedGoogle Scholar
  • 12 Bocci V, Luzzi E, Corradeschi F, Paulesu L. Studies on the biological effects of ozone: 5. Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapy. Biotherapy 1993-1994 7 (02) 83-90
    CrossrefPubMedGoogle Scholar
  • 13 Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm 1998; 7 (05) 313-317
    CrossrefPubMedGoogle Scholar
  • 14 Borrelli E. Mechanism of action of oxygen ozone therapy in the treatment of disc herniation and low back pain. Acta Neurochir Suppl (Wien) 2011; 108 (108) 123-125
    CrossrefPubMedGoogle Scholar
  • 15 Gulmen S, Kurtoglu T, Meteoglu I, Kaya S, Okutan H. Ozone therapy as an adjunct to vancomycin enhances bacterial elimination in methicillin resistant Staphylococcus aureus mediastinitis. J Surg Res 2013; 185 (01) 64-69
    CrossrefPubMedGoogle Scholar
  • 16 Song M, Zeng Q, Xiang Y. et al. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol Med Rep 2018; 17 (02) 2449-2455
    PubMedGoogle Scholar
  • 17 Fontes B, Cattani Heimbecker AM, de Souza Brito G. et al. Effect of low-dose gaseous ozone on pathogenic bacteria. BMC Infect Dis 2012; 12: 358
    CrossrefPubMedGoogle Scholar
  • 18 Ali E. Ozone application for preventing fungal infection. Diabetalogia Croat 2013; 42 (01) 3-9
    PubMedGoogle Scholar
  • 19 Wells KH, Latino J, Gavalchin J, Poiesz BJ. Inactivation of human immunodeficiency virus type 1 by ozone in vitro. Blood 1991; 78 (07) 1882-1890
    CrossrefPubMedGoogle Scholar
  • 20 Schwartz A, Martínez-Sánchez G. (2012). Ozono therapy and its Scientific Foundations. Rev Española Ozonoterapia 2 (01) 199-232 https://www.google.com/url?sa=t&source=web&rct=j&url=https://dialnet.unirioja.es/descarga/articulo/5506701.pdf&ved=2ahUKEwjBn67YwZbxAhXi7XMBHek8DDEQFnoECAgQAQ&usg=AOvVaw0cZUzHabKkQqtPs3HR832V
    PubMedGoogle Scholar
  • 21 Rosul MV, Patskan BM. Ozone therapy effectiveness in patients with ulcerous lesions due to diabetes mellitus. Wiad Lek 2016; 69 (01) 7-9
    PubMedGoogle Scholar
  • 22 Izadi M, Kheirjou R, Mohammadpour R. et al. Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing. Diabetes Metab Syndr 2019; 13 (01) 822-825
    CrossrefPubMedGoogle Scholar